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Calcineurin Does Not Mediate Exercise-Induced
Increase in Muscle GLUT4
Pablo M. Garcia-Roves, Terry E. Jones, Kenichi Otani, Dong-Ho Han, and John O. Holloszy
Exercise induces a rapid increase in expression of the
GLUT4 isoform of the glucose transporter in skeletal
muscle. One of the signals responsible for this adapta-
tion appears to be an increase in cytosolic Ca2. Myo-
cyte enhancer factor 2A (MEF2A) is a transcription
factor that is involved in the regulation of GLUT4
expression. It has been reported that the Ca2-regu-
lated phosphatase calcineurin mediates the activation
of MEF2 by exercise. It has also been shown that the
expression of activated calcineurin in mouse skeletal
muscle results in an increase in GLUT4. These findings
suggest that increases in cytosolic Ca2 induce in-
creased GLUT4 expression by activating calcineurin.
However, we have obtained evidence that this response
is mediated by a Ca2-calmodulindependent protein
kinase. The purpose of this study was to test the
hypothesis that calcineurin is involved in mediating
exercise-induced increases in GLUT4. Rats were exer-
cised on 5 successive days using a swimming protocol.
One group of swimmers was given 20 mg/kg body weight
of cyclosporin, a calcineurin inhibitor, 2 h before exer-
cise. A second group was given vehicle. GLUT4 protein
was increased 80%, GLUT4 mRNA was increased 2.5-
fold, MEF2A protein was increased twofold, and hexoki-
nase II protein was increased 2.5-fold 18 h after the
last exercise bout. The cyclosporin treatment com-
pletely inhibited calcineurin activity but did not affect
the adaptive increases in GLUT4, MEF2A, or hexoki-
nase expression. We conclude that calcineurin activa-
tion does not mediate the adaptive increase in GLUT4
expression induced in skeletal muscle by exercise.
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E
xercise induces a rapid increase in the expres-
sion of the GLUT4 isoform of the glucose trans-
porter in skeletal muscle (1). This is one of the
more important health benefits of exercise, as it
counters insulin resistance by increasing the responsive-
ness of the glucose transport process in muscle to insulin
(2). Increases in cytosolic Ca2 can induce an increase in
GLUT4 expression in muscle cells, and it seems likely that
Ca2 is one of the signals that activate the pathway(s) by
which exercise increases GLUT4 expression in skeletal
muscle (3). It has been reported that the calcium-regulated
phosphatase calcineurin mediates the exercise-induced
activation of MEF2 in muscle (4). Myocyte enhancer factor
2A (MEF2A) is a transcription factor involved in the
regulation of GLUT4 expression (5,6). It has also been
shown that the expression of activated calcineurin in
mouse skeletal muscle results in increased expression of
GLUT4 (7).
These findings suggest that increases in cytosolic Ca2
mediate increased expression of GLUT4 in muscle by
activating calcineurin. In contrast, studies in which cyto-
solic Ca2 levels were raised by exposing L6 myotubes or
rat skeletal muscles to caffeine or ionomycin have pro-
vided evidence that the induction of increased GLUT4
expression by Ca2 is mediated by activation of Ca2-
calmodulindependent protein kinase (CAMK) (3). In
light of this apparent discrepancy, the purpose of the
present study was to evaluate the role of calcineurin in
mediating exercise-induced increases in GLUT4 expres-
sion. To this end, we determined the effect of the cal-
cineurin inhibitor cyclosporin on the adaptive response of
muscle GLUT4 to exercise.
RESEARCH DESIGN AND METHODS
Sandimmune (cyclosporin A; CsA) was purchased from Novartis (Cambridge,
MA). A Biomol Green Cellular Calcineurin Assay Kit PLUS was purchased
from Biomol (Plymouth Meeting, PA). A polyclonal antibody specific for
GLUT4 was the generous gift of Dr. Mike Mueckler (Washington University,
St. Louis, MO). The goat anti-human hexokinase II and rabbit anti-human
MEF2A antibodies were purchased from Santa Cruz Biotechnology (Santa
Cruz, CA). Horseradish peroxidaseconjugated donkey anti-rabbit and don-
key anti-goat IgG were purchased from Jackson ImmunoResearch (West
Grove, PA). Reagents for enhanced chemiluminescence (ECL) were obtained
from Amersham (Arlington Heights, IL). TRIzol reagent for isolation of RNA
was purchased from Gibco-BRL (Grand Island, NY). Reagents for isolation of
mRNA were obtained from Ambion (Austin, TX). The ImProm-II Reverse
Transcription System and PCR Master Mix were purchased from Promega
(Madison, WI). All other reagents were obtained from Sigma (St. Louis, MO).
This research was approved by the Animal Studies Committee of the
Washington University School of Medicine (St. Louis, MO). Male Wistar rats
(body mass 180–200 g) were obtained from Charles River (Wilmington, MA)
and maintained on a diet of Purina chow and water. Animals were randomly
assigned to the exercise  CsA treatment group, exercise  vehicle group,
sedentary  vehicle group, or sedentary  CsA group. Rats in the exercise
groups were accustomed to swimming for 10 min/day for 2 days. They were
then exercised on 5 successive days using a previously described swimming
protocol (2) that involves two 3-h swimming sessions separated by a 45-min
rest period during which the rats are kept warm and given food and water.
After completing the swimming on the 5th day, the animals were fasted
overnight.
Animals were injected once daily subcutaneously between the shoulder
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blades with CsA (20 mg/kg body mass) or an equal volume of vehicle
(Cremophor EL-650 mg/ml and 32.9% ethanol) 2 days before starting the
exercise (8). The animals that were not given cyclosporin had their food
intake decreased so that they gained weight at the same rate as the animals
given cyclosporin. During the exercise training period, the CsA injections
were given 2 h before exercise. Fasted rats were killed 18 h after the last
exercise bout and 2–3 h after the last injection of CsA or vehicle. The animals
were anesthetized with an intraperitoneal injection of pentobarbital sodium (5
mg/100 g body mass), the epitrochlearis and triceps muscles were dissected
out, and a blood sample was drawn from the aorta.
Calcineurin activity. A Biomol Green Cellular Calcineurin Assay Kit PLUS
was used to measure calcineurin (protein phosphatase 2B) activity in skeletal
muscle homogenates.
Cyclosporin assay. The cyclosporin concentration in blood was measured
using the Dade Dimension CsA immunoassay, which was performed using a
Flex reagent cartridge (Dade Behring, Newark, DE) (9).
Western blot analysis. Muscles were homogenized in ice-cold 250 mmol/l
sucrose containing 20 mmol/l HEPES and 1 mmol/l EDTA (pH 7.4). The
protein concentration was measured by the method of Lowry et al. (10).
Aliquots of homogenate were solubilized in Laemmli buffer, subjected to
SDS-PAGE, and transferred to nitrocellulose membranes (Amersham Bio-
sciences, Piscataway, NJ). The membranes were blocked for 1 h at room
temperature with 5% nonfat milk in PBS containing 0.1% Tween 20. The
membranes were probed with the following primary antibodies: anti-GLUT4,
antihexokinase II, and anti-MEF2A, and incubated with 1% nonfat milk in
PBS containing 0.1% Tween 20 overnight at 4°C. The blots were then
incubated with the appropriate horseradish peroxidaseconjugated second-
ary antiimmunoglobulin G antibody. Antibody bound protein was detected
by ECL.
GLUT4 mRNA assay. GLUT4 mRNA was measured using competitive
RT-PCR, as previously described (11).
Statistics. Data are expressed as means  SE. Statistically significant
differences were determined using unpaired Student’s t tests.
RESULTS
Food intake and body weights. Cyclosporin treatment
decreased rats’ food intake to 16 g per day compared
with 19 g per day for the vehicle-treated rats. We,
therefore, reduced the food intake of the vehicle-treated
rats to keep their rate of weight gain similar to that of the
cyclosporin-treated animals. Final body weights averaged
224  5 g for the vehicle-treated swimmers, 225  4 g for
the cyclosporin-treated swimmers, 221  3 g for the
vehicle-treated sedentary controls, and 220  4 g for the
cyclosporin-treated sedentary rats.
Inhibition of calcineurin. The cyclosporin treatment
resulted in a serum cyclosporin concentration of 4.5
g/ml, measured 2–3 h after the final injection of cyclo-
sporin, when the animals were killed. Calcineurin activity
averaged 0.95  0.11 nmol  min1  mg muscle protein1
in the triceps muscle of the vehicle-injected rats and was
undetectable in muscle from cyclosporin-treated rats. Fur-
ther evidence that the cyclosporin treatment was effective
in inhibiting calcineurin was provided by the finding that
an exercise-induced increase in cytochrome oxidase sub-
unit 1, which averaged 150% in the vehicle-treated swim-
mers, was completely blocked in the cyclosporin-treated
swimmers (data not shown).
Adaptive responses in gene expression. The findings in
the sedentary  vehicle and sedentary CsA groups were
similar, so only the data on the vehicle-treated sedentary
control group are shown in the figures. As seen in Fig. 1,
the expression of MEF2A protein was increased approxi-
mately twofold in epitrochlearis muscle 18 h after the last
exercise bout. MEF2A is a transcription factor involved in
the induction of GLUT4 expression (5,6,12). The inhibition
of calcineurin had no effect on the adaptive increase in
MEF2A protein.
GLUT4 protein in the epitrochlearis muscle was in-
creased 80% (Fig. 2A) and GLUT4 mRNA was increased
2.5-fold (Fig. 2B) 18 h after the last exercise bout.
Inhibition of calcineurin did not affect the adaptive in-
creases of GLUT4 mRNA or protein.
Hexokinase expression appears to be regulated in par-
allel with GLUT4 expression in skeletal muscle (1). As
shown in Fig. 3, hexokinase II protein expression was
increased 2.5-fold in epitrochlearis muscle of the exer-
cised animals. Inhibition of calcineurin had no effect on
the adaptive increase in hexokinase.
DISCUSSION
The results of this study show that the inhibition of
calcineurin does not prevent the adaptive increases in
GLUT4, MEF2A, or hexokinase induced in skeletal muscle
by exercise. The exercise-induced increases in the expres-
sion of GLUT4 and MEF2A are mimicked by raising
cytosolic Ca2 in L6 myotubes or epitrochlearis muscles
(3). A number of studies have shown that activation of
FIG. 1. MEF2A protein level is increased in ep-
itrochlearis muscles of rats after five daily bouts
of swimming. The sendentary control rats and the
animals in one group of swimmers were given an
injection of vehicle (V), and the rats in the other
group of swimmers were given cyclosporin A
(CsA) injections 2 h prior to each exercise ses-
sion. Muscles were harvested 18 h after the last
exercise session. The bars represent means  SE
for five rats per group. *P < 0.05.
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calcineurin induces the slow, oxidative muscle fiber gene
regulatory program in skeletal muscle (13–15). It has also
been reported that activation of MEF2 by muscle contrac-
tions is mediated by dephosphorylation of MEF2 by cal-
cineurin (4,15). On the basis of these studies, it has been
concluded that there is a direct correlation between cal-
cineurin activity and expression of the genes that are tran-
scriptionally activated by muscle contractions, and that
calcineurin mediates this effect by activating MEF2 (4).
MEF2A regulates the expression of GLUT4 (5,6). Fur-
thermore, expression of a constitutively active form of
calcineurin in mouse skeletal muscle results in increased
expression of GLUT4 (7). In light of the evidence that
calcineurin activates MEF2 and increases GLUT4 expres-
sion, our finding that the inhibition of calcineurin does not
prevent the exercise-induced increase in GLUT4 may seem
surprising. However, we have found that the CAMK inhib-
itor KN93 completely blocks the increase in GLUT4 ex-
pression induced by raising cytosolic Ca2 in myocytes
(3). This finding provided evidence that the increase in
myocyte GLUT4 induced by Ca2 is mediated by CAMK,
not calcineurin, and thus fits with the present results
showing that inhibition of calcineurin does not prevent
exercise-induced increases in GLUT4. Although the effect
of inhibiting CAMK was evaluated using L6 myotubes (3),
it has also been shown that contractions result in in-
creased phosphorylation (on thr 287) of CAMK-II, the
CAMK isoform found in skeletal muscle (16), and that the
CAMK inhibitor KN62 completely blocks activation of
CAMK-II in rat epitrochlearis muscles (17). Calcineurin
FIG. 2. Effects of five daily bouts of swimming on
GLUT4 protein level (A) in epitrochlearis muscles
and GLUT4 mRNA level (B) in triceps muscles.
Rats were treated with cyclosporin A (CsA) or
vehicle (V) as described in Fig. 1. The bars in A
represent means  SE for six rats in the Seden-
tary-V and Exercise-V groups and nine rats in the
Exercise-CsA group. *P < 0.01 vs. Sedentary-V.
The bars in B represent means  SE for six rats
per group.
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mediates conversion of fast-twitch to slow-twitch skeletal
muscle fibers (13–15). Short-term endurance exercise does
not cause conversion of fast to slow fibers (18), so this
mechanism is not responsible for the exercise-induced
increase in GLUT4 expression. However, it seems likely
that fast to slow fiber conversion mediates the increase in
GLUT4 in muscles of mice overexpressing calcineurin.
Wu et al. (4) have reported that exercise training does
not result in an increase in the abundance of MEF2A in
skeletal muscle. However, we found that exercise does
induce increased expression of MEF2A in muscle (Fig. 1).
This finding is in keeping with our previous observation
that raising cytosolic Ca2 in L6 myotubes or epitrochle-
aris muscle also induces an increase in MEF2A protein (3).
Recent studies have provided insights regarding a possible
mechanism that may explain this increase in MEF2A.
Exercise induces an increase in the expression and DNA
binding activity of the transcription activator nuclear
respiratory factor 1 (NRF-1) in muscle (19,20). We have
also found that overexpression of NRF-1 in skeletal mus-
cle of mice results in increased expression of MEF2A and
GLUT4 (21). At that time, it was not known whether NRF-1
activated transcription of MEF2A, so it was not clear
whether the increased expression of MEF2A was mediated
directly by NRF-1 or was a secondary consequence of
another effect of NRF-1. However, Gulick (22) has recently
shown that the MEF2A promoter has an NRF-1 binding
site. Furthermore, MEF2A promoter-reporters transfected
into myocytes demonstrate NRF-1 elementdependent
promoter activity (22).
It seems likely that the increase in MEF2A expression
plays a role in maintaining the exercise-induced increase
in GLUT4 between exercise sessions. However, because
the time course of the increases in MEF2A and GLUT4
proteins after a bout of exercise appear to be similar
(P.M.G.R. and J.O.H., unpublished observations), it does
not seem possible that the increased expression of MEF2A
could mediate the initial increase in GLUT4 transcription
induced by exercise/Ca2. Instead, it is probable that ac-
tivation of preexisting MEF2A is responsible for inducing
the initial increase in GLUT4 transcription during exercise.
In light of our finding that inhibition of calcineurin does
not affect the exercise-induced increase in GLUT4, we
suggest the following alternative mechanism. The tran-
scriptional activity of MEF2A is repressed by the binding
of class II histone deacetylases (HDACs) to its DNA
binding domain (21). CAMK phosphorylates HDACs, caus-
ing dissociation of MEF2A from HDACs with an unmask-
ing of MEF2’s transcriptional activity (23). MEF2A is
further activated through phosphorylation by the p38
mitogen-activated protein kinase (MAPK) (24,25). Direct
evidence in support of this mechanism was provided by a
recent study on contracting human skeletal muscle by
McGee and Hargreaves (26). Regarding the roles of CAMK
and p38 MAPK, it is of interest that Enslen et al. (27) have
shown that p38 MAPK can be activated via a pathway in
which p38 MAPK lies downstream of CAMK.
In conclusion, it appears that activation of calcineurin in
muscle during exercise is not involved in mediating the
exercise-induced increase in GLUT4. This conclusion is
based on our finding that inhibition of calcineurin does not
prevent the increase in GLUT4. McGee and Hargreaves
(26) arrived at the same conclusion on the basis of their
finding that exercise does not result in nuclear transloca-
tion of nuclear factor of activated T-cells. Calcineurin is
involved in mediating the conversion of fast- to slow-
twitch muscle fibers (14).
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